Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (48 quarters reported)
$127M in Q4 2014 → $529M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Anteris Technologies Global | 7.6% | Trimmed 6.6% | 5,179,464 | $40.2M |
| GM Globus Med Inc | 6.7% | Added 58% | 476,109 | $35.7M |
| Gsk PLC | 6.1% | Added 54% | 671,121 | $32.3M |
| IP Icon Pub Ltd Co | 4.5% | Added 60% | 140,999 | $24M |
| SH Senseonics Hldgs Inc | 4.4% | Added 44% | 2,290,860 | $23.3M |
| Merck & Co Inc Put | 4.1% | New | 150,000 | $21.8M |
| Merck & Co Inc | 4.0% | New | 145,485 | $21.1M |
| Ideaya Biosciences Inc | 3.6% | Added 4.1% | 500,117 | $19.2M |
| Pfizer Inc Put | 3.2% | New | 600,000 | $17.1M |
| SL Sellas Life Sciences Group I Put | 2.9% | Unchanged | 1,230,700 | $15.1M |
| SS Sanofi Sa | 2.8% | Trimmed 2.2% | 356,182 | $14.7M |
| AT Allogene Therapeutics Inc | 2.8% | Trimmed 32% | 9,104,151 | $14.6M |
| Maximus Inc | 2.7% | Trimmed 62% | 268,280 | $14.3M |
| Relmada Therapeutics Inc | 2.6% | Added 262% | 3,629,844 | $13.7M |
| Viatris Inc | 2.5% | Trimmed 21% | 755,490 | $13.4M |
| AH Aveanna Healthcare Hldgs Inc | 2.4% | Added 174% | 1,012,102 | $12.6M |
| Replimune Group Inc | 2.2% | New | 865,331 | $11.5M |
| Tango Therapeutics Inc | 2.0% | Added 106% | 428,860 | $10.7M |
| Ani Pharmaceuticals Inc | 2.0% | Added 50% | 146,268 | $10.6M |
| Biomarin Pharmaceutical Inc | 2.0% | New | 174,311 | $10.5M |
| Celcuity Inc | 1.9% | Added 15% | 126,339 | $10M |
| Astrazeneca PLC | 1.9% | New | 61,848 | $9.99M |
| Rapport Therapeutics Inc | 1.9% | Trimmed 5.3% | 291,231 | $9.79M |
| Vir Biotechnology Inc | 1.8% | Trimmed 19% | 873,375 | $9.76M |
| The Cigna Group | 1.7% | Trimmed 41% | 33,935 | $9.22M |
| CC Cooper Cos Inc | 1.7% | New | 158,053 | $8.93M |
| Liquidia Corporation | 1.6% | New | 282,000 | $8.53M |
| Cybin Inc | 1.3% | Trimmed 57% | 561,289 | $6.9M |
| Protara Therapeutics Inc | 1.1% | Added 3.6% | 1,991,339 | $6.07M |
| Pmv Pharmaceuticals Inc | 1.1% | Added 38% | 3,634,137 | $6.07M |
| Aquestive Therapeutics Inc | 1.1% | Trimmed 14% | 1,278,056 | $5.92M |
| Ptc Therapeutics Inc | 1.0% | New | 82,900 | $5.37M |
| CP Corbus Pharmaceuticals Hldgs | 1.0% | New | 766,364 | $5.23M |
| RA Rainier Acquisition Corp | 1.0% | New | 500,000 | $5.1M |
| HM Haemonetics Corp Mass Put | 0.9% | New | 44,700 | $4.71M |
| Q32 Bio Inc | 0.8% | New | 529,155 | $4.38M |
| Serina Therapeutics Inc | 0.8% | Added 100% | 2,000,000 | $4M |
| Bright Minds Biosciences Inc | 0.7% | Added 1.6% | 75,152 | $3.74M |
| Savara Inc | 0.6% | Added 6.4% | 657,104 | $3.39M |
| Onkure Therapeutics Inc | 0.6% | Added 0.4% | 1,082,965 | $2.95M |
| An2 Therapeutics Inc | 0.6% | Added 3.4% | 548,103 | $2.92M |
| Immunome Inc | 0.5% | Added 6.4% | 132,097 | $2.84M |
| Zenas Biopharma Inc | 0.5% | Trimmed 54% | 95,457 | $2.57M |
| Ovid Therapeutics Inc | 0.5% | Unchanged | 1,005,334 | $2.5M |
| Aligos Therapeutics Inc | 0.3% | Unchanged | 327,237 | $1.84M |
| Fulcrum Therapeutics Inc | 0.3% | New | 481,601 | $1.78M |
| Alignment Healthcare Inc | 0.3% | New | 184,424 | $1.5M |
| Xilio Therapeutics Inc | 0.3% | Unchanged | 152,464 | $1.38M |
| Eyepoint Inc | 0.2% | Trimmed 40% | 373,666 | $1.22M |
| QI Qt Imaging Hldgs Inc | 0.2% | Added 2791% | 440,446 | $1.12M |
| Ibio Inc | 0.2% | Unchanged | 904,268 | $1.07M |
| Tela Bio Inc | 0.1% | Unchanged | 636,300 | $732K |
| Enveric Biosciences Inc | 0.1% | Added 83% | 330,000 | $490K |
| NM Neuroone Med Technologies Co | 0.0% | Unchanged | 82,767 | $85.3K |
| MM Modular Med Inc | 0.0% | Unchanged | 26,190 | $52.4K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 16, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cencora Inc | Exited | −173,588 | −$49.1M | — |
| Maximus Inc | Trimmed | −446,987 | −$23.8M | 2.7% |
| Tyra Biosciences Inc | Exited | −695,315 | −$22.2M | — |
| Merck & Co Inc | New | +150,000 | +$21.8M | 4.1% |
| Merck & Co Inc | New | +145,485 | +$21.1M | 4.0% |
| WH Waystar Hldg Corp | Exited | −925,834 | −$19M | — |
| Pfizer Inc | New | +600,000 | +$17.1M | 3.2% |
| Oruka Therapeutics Inc | Exited | −177,118 | −$16.9M | — |
| CC Cross Ctry Healthcare Inc | Exited | −1,098,393 | −$14.5M | — |
| GM Globus Med Inc | Added | +174,293 | +$13.1M | 6.7% |
Showing the 10 largest of 66 changes.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IP Icon Pub Ltd Co | Trimmed | −218,172 | −$37.9M | 2.5% |
| Dianthus Therapeutics Inc | Trimmed | −310,791 | −$30.3M | 1.0% |
| AT Allogene Therapeutics Inc | New | +13,323,431 | +$27.7M | 4.6% |
| Corcept Therapeutics Inc | Exited | −674,759 | −$27.2M | — |
| Livanova PLC | Exited | −421,615 | −$26.8M | — |
| GM Globus Med Inc | New | +301,816 | +$23.8M | 3.9% |
| Cencora Inc | Added | +72,694 | +$20.6M | 8.1% |
| SL Sellas Life Sciences Group I | New | +1,230,700 | +$18.2M | 3.0% |
| Ideaya Biosciences Inc | New | +480,383 | +$17.9M | 3.0% |
| Embecta Corp | Exited | −1,847,850 | −$16.3M | — |
Showing the 10 largest of 82 changes.
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| The Cigna Group | Exited | −172,203 | −$47.4M | — |
| SS Sanofi Sa | Trimmed | −732,015 | −$35.3M | 1.7% |
| Celcuity Inc | Trimmed | −283,224 | −$32.3M | 3.2% |
| Zimmer Biomet Holdings Inc | Trimmed | −323,029 | −$29.2M | 0.8% |
| Rhythm Pharmaceuticals Inc | Exited | −265,700 | −$28.4M | — |
| Corcept Therapeutics Inc | New | +674,759 | +$27.2M | 3.9% |
| Cencora Inc | Added | +84,994 | +$26.7M | 4.5% |
| Kenvue Inc | Exited | −1,465,442 | −$25.3M | — |
| WH Waystar Hldg Corp | Added | +1,028,511 | +$24.8M | 5.7% |
| Gsk PLC | New | +385,879 | +$21.3M | 3.1% |
Showing the 10 largest of 79 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| The Cigna Group | New | +172,203 | +$47.4M | 7.5% |
| Zimmer Biomet Holdings Inc | New | +385,642 | +$34.7M | 5.5% |
| Celcuity Inc | Trimmed | −309,459 | −$30.9M | 7.5% |
| Rhythm Pharmaceuticals Inc | New | +265,700 | +$28.4M | 4.5% |
| Organon & Co | New | +3,421,765 | +$24.5M | 3.9% |
| Icon PLC | New | +127,202 | +$23.2M | 3.6% |
| WH Waystar Hldg Corp | New | +613,725 | +$20.1M | 3.2% |
| Livanova PLC | New | +322,382 | +$19.8M | 3.1% |
| SS Sanofi Sa | Added | +408,983 | +$19.8M | 7.4% |
| Disc Medicine Inc | Trimmed | −227,201 | −$18M | 0.7% |
Showing the 10 largest of 61 changes.
quarter ended September 30, 2025 · filed November 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Celcuity Inc | New | +786,526 | +$38.9M | 9.8% |
| Alkermes PLC | New | +674,840 | +$20.2M | 5.1% |
| Bright Minds Biosciences Inc | Trimmed | −321,574 | −$19.5M | 2.9% |
| SS Sanofi Sa | Added | +375,203 | +$17.7M | 6.7% |
| Henry Schein Inc | New | +219,207 | +$14.5M | 3.7% |
| GM Globus Med Inc | Exited | −245,570 | −$14.5M | — |
| Kenvue Inc | New | +844,000 | +$13.7M | 3.5% |
| Dianthus Therapeutics Inc | Added | +341,680 | +$13.4M | 5.8% |
| Neurocrine Biosciences Inc | Exited | −100,725 | −$12.7M | — |
| Gsk PLC | New | +268,873 | +$11.6M | 2.9% |
Showing the 10 largest of 49 changes.
quarter ended June 30, 2025 · filed August 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icon PLC | Exited | −203,311 | −$35.6M | — |
| Zimmer Biomet Holdings Inc | Exited | −187,685 | −$21.2M | — |
| Labcorp Holdings Inc | Exited | −83,873 | −$19.5M | — |
| Teleflex Incorporated | Exited | −107,780 | −$14.9M | — |
| CD Centene Corp Del | New | +262,500 | +$14.2M | 5.4% |
| Disc Medicine Inc | Added | +211,276 | +$11.2M | 5.8% |
| Neurocrine Biosciences Inc | Trimmed | −86,848 | −$10.9M | 4.8% |
| Embecta Corp | Trimmed | −1,076,444 | −$10.4M | 0.1% |
| IL Idexx Labs Inc | New | +18,000 | +$9.65M | 3.7% |
| Sanofi | New | +187,500 | +$9.06M | 3.5% |
Showing the 10 largest of 59 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| The Cigna Group | Exited | −98,003 | −$27.1M | — |
| Merck & Co Inc | New | +270,596 | +$24.3M | 7.2% |
| Neurocrine Biosciences Inc | New | +187,573 | +$20.7M | 6.2% |
| Sanofi | Exited | −387,000 | −$18.7M | — |
| GM Globus Med Inc | New | +207,000 | +$15.2M | 4.5% |
| Biomarin Pharmaceutical Inc | New | +141,134 | +$9.98M | 3.0% |
| Viatris Inc | Exited | −730,000 | −$9.09M | — |
| Organon & Co | Exited | −606,410 | −$9.05M | — |
| Embecta Corp | Added | +682,039 | +$8.7M | 4.2% |
| HM Haemonetics Corp Mass | New | +133,966 | +$8.51M | 2.5% |
Showing the 10 largest of 47 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icon PLC | New | +195,500 | +$41M | 11.5% |
| Intuitive Surgical Inc | Exited | −59,000 | −$29M | — |
| Teva Pharmaceutical Industries Ltd | Exited | −1,349,274 | −$24.3M | — |
| The Cigna Group | Added | +71,500 | +$19.7M | 7.6% |
| Sanofi | New | +387,000 | +$18.7M | 5.3% |
| Maximus Inc | Added | +226,281 | +$16.9M | 8.0% |
| Bright Minds Biosciences Inc | New | +451,793 | +$16.3M | 4.6% |
| Labcorp Holdings Inc | Trimmed | −60,000 | −$13.8M | 7.3% |
| Anteris Technologies Global | New | +2,370,000 | +$13.2M | 3.7% |
| Kenvue Inc | Exited | −474,741 | −$11M | — |
Showing the 10 largest of 46 changes.
Loading...